OC-072 The Toppic Trial: A Randomised, Double-Blind Parallel Group Trial of Mercaptopurine VS Placebo to Prevent Recurrence of Crohn’s Disease Following Surgical Resection in 240 Patients

I Arnott; C Mowat; H Ennis; C Keerie; S Lewis; A Cahill; J Morris; M Dunlop; S Bloom; J Lindsay; S Subramanian; J Satsangi; on behalf of TOPPIC Trial Study Group

doi:10.1136/gutjnl-2016-312388.71

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Hosted content
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

BSG 2016

OC-072 The Toppic Trial: A Randomised, Double-Blind Parallel Group Trial of Mercaptopurine VS Placebo to Prevent Recurrence of Crohn’s Disease Following Surgical Resection in 240 Patients

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Arnott I, Mowat C, Ennis H, et al

OC-072 The Toppic Trial: A Randomised, Double-Blind Parallel Group Trial of Mercaptopurine VS Placebo to Prevent Recurrence of Crohn’s Disease Following Surgical Resection in 240 Patients

Gut 2016;65:A43-A44.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password